SNT 25.7% 4.4¢ syntara limited

insight, page-3

  1. 34,336 Posts.
    lightbulb Created with Sketch. 9075
    PXS 39c only $120m, cash possible $91m at the moment ($62m on 31/12/12 + $40m from NovaQuest Pharma - $11m cash outflow for Mar 2013 quarter = $91m)

    E/V is only around $29m. PXS is presenting good value at current price.
 
watchlist Created with Sketch. Add SNT (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.